• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Altasciences Contributes to Vibegron Approval

    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement

    Pfizer Selects Seven Bridges to Support RNA Sequencing Data

    ACG Launches ACG Laboratories

    Glatt and Aprecia Enter 3D-Printing Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Why Increasing Solubility May Not Improve Bioavailability - In Vitro Predictions

    ACG Launches ACG Laboratories

    Glatt and Aprecia Enter 3D-Printing Collaboration

    Catalent Acquires Delphi Genetics

    Almac Group Completes $7M R&D Center
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing

    PwC Joins Medicines Manufacturing Innovation Centre

    AARDEX Group Partners with Pill Connect

    Phillips-Medsize and Subcuject Collaborate
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Altasciences Contributes to Vibegron Approval

    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement

    Why Increasing Solubility May Not Improve Bioavailability - In Vitro Predictions

    Pfizer Selects Seven Bridges to Support RNA Sequencing Data

    ACG Launches ACG Laboratories
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Almac Group

    Emergent BioSolutions

    Syngene

    Aphena Pharma Solutions

    Baxter BioPharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Adare Pharma Solutions

    PCI Pharma Services

    Reed-Lane

    Syngene

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Vetter Moves Into New HQ

    €50 million investment integrates the latest construction and environmental standards.

    Vetter Moves Into New HQ
    Vetter’s new HQ is designed for around 1,000 employees and includes the new ATRIUM company restaurant, a cafeteria and about 40 conference rooms.
    Related CONTENT
    • 20th Annual Contracting & Outsourcing Conference & Exhibition
    • Lonza Capsules and Health Ingredients
    • PCI Pharma Services
    • Catalent Pharma Solutions
    • Regis Custom Pharma
    Contract Pharma Staff10.21.20
    Vetter, a global contract development and manufacturing organization (CDMO), has moved into its new headquarters in Ravensburg, Germany. The opening of the new building, known as Ravensburg Vetter Kammerbruehl. While the situation regarding the coronavirus continues to shift, Vetter is doing what is necessary to continue being a stable and reliable partner for its customers and suppliers. As a CDMO, the company works together with its clients to continue enabling the supply of oftentimes life-saving drugs to patients worldwide.
     
    With the realization of the new corporate headquarters, Vetter is responding to the continuous growth of headcount and changing circumstances. “We are relying on sustainable and future-oriented activities with the focus on our customers and their patients,” said Peter Soelkner, managing director, Vetter. “The new building is designed for around 1,000 employees. In addition to an appropriate level of office space, it includes the new ATRIUM company restaurant, a cafeteria and about 40 conference rooms. Vetter attaches great importance to modernity and, as such, has invested roughly €50 million in a building that integrates the latest construction and environmental standards.”
     
    The former headquarters, Ravensburg Vetter Verwaltung, was modified to be used as a training center to house the Vetter Academy. Through this education center the company offers employees qualification programs and individual development opportunities on a continuous basis. In addition, a separate floor in the building is now used as an audit and conference location.
     
    The CDMO has set also high goals for its other sites. Most recently, a new combination building for manual visual inspection and secondary packaging started operations at the Ravensburg Vetter Sued / Vetter Secondary Packaging site. Furthermore, a new cleanroom for the manufacturing of prefilled syringes is planned for going operational at the Schuetzenstrasse site in 2021. At this location, Vetter has also secured an adjoining plot of land for a further production building. Meanwhile, the recently purchased clinical manufacturing site in Rankweil, Austria, is designed to be ready for the first drug products in development in the second half of 2021.
     
    “Part of our 360-degree approach includes investments in the expansion of our development capacities,” said Soelkner. “We have observed a steady increase in demand from our customers as well as ever-more complex requirements for modern compounds.”
     
    The company has responded to these needs at both its Schuetzenstrasse site as well as at the company’s dedicated US clinical manufacturing site. “Our goal is to expand our production capacities sustainably and to align the upstream and downstream areas accordingly,” said managing director Thomas Otto. 
     
    In the coming years, the company also intends to further expand on its quality control resources. Following the recent implementation of another machine for automated visual inspection, the CDMO is planning to purchase three additional units for its Center for Visual Inspection and Logistics.
     
    “We want to provide sufficient resources for the important step of final quality control and, at the same time, create greater flexibility,” said Otto. “These actions will even better enable us to offer our customers either manual or automatic visual inspection depending on individual batch sizes and special characteristics of their products."
    Suggested For You
    20th Annual Contracting & Outsourcing Conference & Exhibition 20th Annual Contracting & Outsourcing Conference & Exhibition
    Lonza Capsules and Health Ingredients Lonza Capsules and Health Ingredients
    PCI Pharma Services PCI Pharma Services
    Catalent Pharma Solutions Catalent Pharma Solutions
    Regis Custom Pharma Regis Custom Pharma
    TraceLink Launches Serialized Product Intelligence Solution TraceLink Launches Serialized Product Intelligence Solution
    Lubrizol Expands Partnership with the Population Council Lubrizol Expands Partnership with the Population Council
    Vetter continues its long-term investment strategy to sustain future growth Vetter continues its long-term investment strategy to sustain future growth
    Cytocom and Cleveland Biolabs Merge Cytocom and Cleveland Biolabs Merge
    GSK to Sell Poznań Manufacturing Site to Delpharm GSK to Sell Poznań Manufacturing Site to Delpharm
    The Discovery Labs Appoints President and COO The Discovery Labs Appoints President and COO
    Rentschler Biopharma and ATUM Ink Licensing Agreement Rentschler Biopharma and ATUM Ink Licensing Agreement
    RedHill Biopharma Ramps-Up Manufacturing of Opaganib RedHill Biopharma Ramps-Up Manufacturing of Opaganib
    CellGenix Expands Facility CellGenix Expands Facility
    Greenwich Lifesciences Completes Manufacturing of GP2 Greenwich Lifesciences Completes Manufacturing of GP2

    Related Breaking News

    • Bioanalytical Services | Breaking News | Industry News | Preclinical Outsourcing
      Altasciences Contributes to Vibegron Approval

      Altasciences Contributes to Vibegron Approval

      Provided clinical support for two drug-drug interaction studies and a bioavailability trial for the overactive bladder treatment.
      Kristin Brooks 02.24.21

    • Breaking News | Drug Development | Industry News
      Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement

      Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement

      Sentynl acquires CUTX-101 Copper Histidinate for the treatment of Menkes disease for $20 million in upfront and regulatory milestones.
      Kristin Brooks 02.24.21

    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Information Technology
      Pfizer Selects Seven Bridges to Support RNA Sequencing Data

      Pfizer Selects Seven Bridges to Support RNA Sequencing Data

      Seven Bridges will centralize and manage terabytes scRNASeq data, which provides detailed analysis of gene expression in individual cells.
      Kristin Brooks 02.24.21


    • Analytical Services | Breaking News | Facilities | Industry News | Laboratory Testing
      ACG Launches ACG Laboratories

      ACG Launches ACG Laboratories

      Opens a process development lab in Shirwal, India.
      Tim Wright, Editor, Contract Pharma 02.23.21

    • Breaking News | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments
      Glatt and Aprecia Enter 3D-Printing Collaboration

      Glatt and Aprecia Enter 3D-Printing Collaboration

      Aprecia's compression-free 3DP manufacturing platform expands Glatt capabilities in innovative particle design.
      Tim Wright, Editor, Contract Pharma 02.23.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
      Catalent Acquires Delphi Genetics

      Catalent Acquires Delphi Genetics

      Launches US plasmid manufacturing site to establish global pDNA development and manufacturing capabilities.
      Tim Wright, Editor, Contract Pharma 02.23.21


    • Analytical Services | Bioanalytical Services | Breaking News | Chemistry | Facilities | Industry News | Laboratory Testing | R&D
      Almac Group Completes $7M R&D Center

      Almac Group Completes $7M R&D Center

      Significant expansion of biocatalysis, flow chemistry, and peptide capacity.
      Tim Wright, Editor, Contract Pharma 02.23.21

    • Breaking News | Collaborations & Alliances
      NovalGen and Halix Enter Strategic Partnership

      NovalGen and Halix Enter Strategic Partnership

      Halix will provide manufacturing of clinical supply of NovalGen’s therapies.
      Charles Sternberg, Assistant Editor 02.22.21

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Avid Bioservices Begins Phase 2 of Myford Mfg. Expansion

      Avid Bioservices Begins Phase 2 of Myford Mfg. Expansion

      Build to include second manufacturing train with both upstream and downstream processing suites.
      Kristin Brooks 02.22.21


    • APIs | Breaking News | Formulation Development | Industry News
      Tris Pharma, Athena Bioscience Enter Exclusive License Agreement

      Tris Pharma, Athena Bioscience Enter Exclusive License Agreement

      Athena gains exclusive rights to commercialize a long-acting antihypertensive product developed using Tris' proprietary technology.
      Kristin Brooks 02.22.21

    • Breaking News | Drug Development | Promotions & Moves
      Aevitas Therapeutics Appoints President and CEO

      Aevitas Therapeutics Appoints President and CEO

      Dr. Markus Peters offers a 25-year track record of developing and commercializing orphan and specialty pharmaceuticals.
      Charles Sternberg, Assistant Editor 02.22.21

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
      MaxiVAX, Minaris Enter Cell Therapy Mfg. Agreement

      MaxiVAX, Minaris Enter Cell Therapy Mfg. Agreement

      Minaris will provide GMP manufacturing, freezing and shipping of the MVX-ONCO-2 capsules from its site near Munich, Germany.
      Kristin Brooks 02.22.21


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      G-CON Manufacturing Delivers & Installs PODs for Cell Therapy Manufacturing

      G-CON Manufacturing Delivers & Installs PODs for Cell Therapy Manufacturing

      Successfully completes the project within the client’s required schedule.
      Charles Sternberg, Assistant Editor 02.19.21

    • Breaking News | CRO News | Industry News
      Eurofins Scientific Acquires Beacon Discovery

      Eurofins Scientific Acquires Beacon Discovery

      Expands its integrated drug discovery capabilities and expertise.
      Charles Sternberg, Assistant Editor 02.19.21

    • Breaking News | Industry News | Information Technology
      Antares Vision Agrees to Acquire rfXcel Corporation

      Antares Vision Agrees to Acquire rfXcel Corporation

      rfXcel’s AI-enabled SaaS platform more than doubles Antares Vision’s software business and adds a high share of contracted, recurring and scalable revenues.
      Charles Sternberg, Assistant Editor 02.19.21

    Trending
    • Century Therapeutics Significantly Expands Capabilities
    • Catalent Acquires Delphi Genetics
    • Sanofi And Translate Bio Expand Vaccine Collaboration
    • RotaChrom Technologies Partners With Cyclolab
    • Inside A Vaccine Trial
    Breaking News
    • Altasciences Contributes to Vibegron Approval
    • Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
    • Pfizer Selects Seven Bridges to Support RNA Sequencing Data
    • ACG Launches ACG Laboratories
    • Glatt and Aprecia Enter 3D-Printing Collaboration
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula
    JRF Technology Debuts Elderberry Oral Film Strip
    Danone Adds to Plant-Based Portfolio with Acquisition of Follow Your Heart Brand
    Coatings World

    Latest Breaking News From Coatings World

    Hempel Launches Sustainability Framework: Futureproof
    ChemQuest Hires Rich Gibson
    New Increase in Kynar Fluoropolymer Capacities at Arkema's Chinese Site
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Terumo to Purchase Predictive Analytics Firm Health Outcomes Sciences
    Abiomed Leader Michael Minogue Named AdvaMed Board Chairman
    TransEnterix Changes Name to Asensus Surgical
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Altasciences Contributes to Vibegron Approval
    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
    Pfizer Selects Seven Bridges to Support RNA Sequencing Data
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Madison Reed Raises $52 Million in Financing Round
    The Estée Lauder Companies Closes Becca Cosmetics
    Afro Sheen Launches New Brand Initiatives
    Happi

    Latest Breaking News From Happi

    PBA Opposes House Bill 2325 in West Virginia
    J.R. Watkins Tackles Pain with New Lines
    RB Launches Vanish Miracle
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Lowe-Martin Adds 2 KODAK NEXFINITY Digital Presses
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Eaglewood Technologies debuts new anilox cleaning system
    INX International and VerifyMe sign supply agreement
    Soma partners with DTM Flexo Services
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    H&V Announces Price Increase
    Fiber Bond VE3 Technology Inactivates SARS-CoV-2 in HVAC Filtration Systems
    Citizens Provides $325 Million Senior Credit Facility to Nice-Pak
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    NuVasive Nabs Simplify Medical for $150M
    SeaSpine Begins Limited Launch of WaveForm TA (TLIF Articulating) 3D-Printed Interbody
    Nexus Spine Implants for Use in Spinal Surgeries Become Available
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    RFID Locks Market to Reach $9.93 Billion by 2027: Allied Market Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login